2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1487668463
Verify on CMS →

SHEILA GUPTA

Endocrinology, Diabetes & Metabolism Physician in ORMOND BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 462 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]

What the federal data shows

SHEILA GUPTA reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 4,601 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
5K
Part D claims, 2023
49%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SHEILA GUPTA's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SHEILA GUPTA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SHEILA GUPTA?

Below national average

NPI registry status

Active

Issued 07/28/2006

NPI 1487668463

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

4,601 74% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Medicare quality performance — MIPS

SHEILA GUPTA's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHEILA GUPTA is a Endocrinology, Diabetes & Metabolism Physician provider practicing in ORMOND BEACH, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1487668463. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SHEILA GUPTA appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider at 345 CLYDE MORRIS BLVD, ORMOND BEACH, FL, 32174, with a listed phone of (386) 673-0075. NPI 1487668463 was issued on 07/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GUPTA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,601 prescription claims written by this provider, covering 462 Medicare beneficiaries and totaling roughly $2.1 million in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

345 CLYDE MORRIS BLVD
ORMOND BEACH, FL 32174

Provider Details

NPI 1487668463
Specialty Endocrinology, Diabetes & Metabolism Physician
Gender Female
NPI Issued 07/28/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Hospital and facility affiliations

Facilities where SHEILA GUPTA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

AMOL K GUPTA MD CORPORATION
ORMOND BEACH, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to SHEILA GUPTA. To verify SHEILA GUPTA's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

SHEILA GUPTA — brand share 51.0%
Specialty average (est.)

51% brand-name claims vs 49% generic, on 4,601 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,601
Total Claims
$2.1M
Total Drug Cost
462
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
10,844
Total Day Supply
321,604
Brand vs Generic
51% brand / 49% generic
Brand Drug Cost
$1.9M
Generic Drug Cost
$51K
Antibiotic Claims
14

Patient Demographics

Average Patient Age
73.8 years
Avg HCC Risk Score
1.69
Gender Split
69% female / 31% male
Age Distribution
<65: 36, 65-74: 215, 75-84: 169, 85+: 42

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
420
Ozempic
Semaglutide
285
Synthroid
Levothyroxine Sodium
280
Rosuvastatin Calcium
210
Metformin Hcl
186
Metformin Hcl Er
Metformin Hcl
162
Atorvastatin Calcium
117
Tresiba Flextouch U-200
Insulin Degludec
103
Farxiga
Dapagliflozin Propanediol
102
Novolog Flexpen
Insulin Aspart
99

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How SHEILA GUPTA fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

SHEILA GUPTA's 4,601 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as GUPTA.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHEILA GUPTA's specialty?
SHEILA GUPTA specializes in Endocrinology, Diabetes & Metabolism Physician and practices in ORMOND BEACH, Florida.
How much does SHEILA GUPTA prescribe under Medicare Part D?
In 2023, SHEILA GUPTA wrote 4,601 Medicare Part D claims totaling $2.1M in drug costs for 462 beneficiaries.
What is SHEILA GUPTA's Medicare quality score?
SHEILA GUPTA has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SHEILA GUPTA located?
SHEILA GUPTA is located at 345 CLYDE MORRIS BLVD, ORMOND BEACH, FL, 32174. Phone: (386) 673-0075.
What is SHEILA GUPTA's NPI number?
SHEILA GUPTA's National Provider Identifier (NPI) is 1487668463, issued on 07/28/2006.
Does SHEILA GUPTA prescribe more brand-name or generic drugs?
SHEILA GUPTA's prescribing is 51% brand-name and 49% generic drugs by claim count, with $1.9M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does SHEILA GUPTA prescribe most often?
Based on 2023 Medicare Part D data, SHEILA GUPTA's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Synthroid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHEILA GUPTA accept Medicare?
SHEILA GUPTA appears in CMS Medicare data with 4,601 Part D claims and 462 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHEILA GUPTA's credentials?
SHEILA GUPTA's NPI is 1487668463. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology